Evidence map›Paper›PMID 33432084›Full record

ArticleScientific reports2021

Safe and effective aerosolization of in vitro transcribed mRNA to the respiratory tract epithelium of horses without a transfection agent.

Rebecca M Legere, Noah D Cohen, Cristina Poveda, Jocelyne M Bray, Rola Barhoumi, Joseph A Szule, Andrés de la Concha-Bermejillo, Angela I Bordin, Jeroen Pollet

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Nebulization of an mRNA-encoded monoclonal antibody for passive immunization of foals against Rhodococcus equi.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  5. Review
  6. Modified mRNA-MediatedInternational journal of molecular sciences · 2024
    Article
  7. Nanotechnology of inhalable vaccines for enhancing mucosal immunity.Drug delivery and translational research · 2024
    Review
  8. COVID-19 mRNA vaccines: Platforms and current developments.Molecular therapy : the journal of the American Society of Gene Therapy · 2022
    Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Rebecca M LegereDepartment of Large Animal Clinical Sciences, College of Veterinary Medicine, Texas A&M University, College Station, TX, USA.
Noah D CohenDepartment of Large Animal Clinical Sciences, College of Veterinary Medicine, Texas A&M University, College Station, TX, USA. ncohen@cvm.tamu.edu.
Cristina PovedaDepartment of Pediatrics, National School of Tropical Medicine, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
Jocelyne M BrayDepartment of Large Animal Clinical Sciences, College of Veterinary Medicine, Texas A&M University, College Station, TX, USA.
Rola BarhoumiDepartment of Veterinary Integrative Biosciences, College of Veterinary Medicine, Texas A&M University, College Station, TX, USA.
Joseph A SzuleDepartment of Veterinary Pathobiology, College of Veterinary Medicine, Texas A&M University, College Station, TX, USA.
Andrés de la Concha-BermejilloTexas A&M Veterinary Medical Diagnostic Laboratory, Texas A&M University, College Station, TX, USA.
Angela I BordinDepartment of Large Animal Clinical Sciences, College of Veterinary Medicine, Texas A&M University, College Station, TX, USA.
Jeroen PolletDepartment of Pediatrics, National School of Tropical Medicine, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA. Jeroen.pollet@bcm.edu.
Texas A&M University · USBaylor College of Medicine · USTexas Children's Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vaccines and therapeutics using in vitro transcribed mRNA hold enormous potential for human and veterinary medicine. Transfection agents are widely considered to be necessary to protect mRNA and enhance transfection, but they add expense and raise concerns regarding quality control and safety. We found that such complex mRNA delivery systems can be avoided when transfecting epithelial cells by aerosolizing the mRNA into micron-sized droplets. In an equine in vivo model, we demonstrated that the translation of mRNA into a functional protein did not depend on the addition of a polyethylenimine (PEI)-derived transfection agent. We were able to safely and effectively transfect the bronchial epithelium of foals using naked mRNA (i.e., mRNA formulated in a sodium citrate buffer without a delivery vehicle). Endoscopic examination of the bronchial tree and histology of mucosal biopsies indicated no gross or microscopic adverse effects of the transfection. Our data suggest that mRNA administered by an atomization device eliminates the need for chemical transfection agents, which can reduce the cost and the safety risks of delivering mRNA to the respiratory tract of animals and humans.

Indexed as

HorsesNasal SpraysRespiratory MucosaAnimalsAnimals, NewbornCells, CulturedDrug CarriersDrug Delivery SystemsEpithelial CellsFemaleLungNebulizers and VaporizersPolyethyleneimineRNA, MessengerTranscription, GeneticTransfectionDrug CarriersNasal SpraysPolyethyleneimineRNA, MessengerVaccines, DNA

Identifiers

PMID33432084
PMCPMC7801524
OpenAlexW3120368938

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.